Detalhe da pesquisa
1.
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.
N Engl J Med
; 382(6): 514-524, 2020 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31826360
2.
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.
Br J Cancer
; 125(5): 679-686, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34158598
3.
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial.
Lancet Oncol
; 21(10): 1283-1295, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33002436
4.
Immunotherapy and targeted therapy combinations in metastatic breast cancer.
Lancet Oncol
; 20(3): e175-e186, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30842061
5.
Breast cancer risk in relation to plasma metabolites among Hispanic and African American women.
Breast Cancer Res Treat
; 176(3): 687-696, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-30771047
6.
Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
Breast Cancer Res Treat
; 173(2): 329-341, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30341462
7.
Correction to: Breast cancer risk in relation to plasma metabolites among Hispanic and African American women.
Breast Cancer Res Treat
; 176(3): 697, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31154579
8.
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study.
Invest New Drugs
; 37(2): 345-351, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30610588
9.
RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor ß signaling.
J Biol Chem
; 292(18): 7435-7451, 2017 05 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28292929
10.
High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts.
Int J Cancer
; 143(11): 3027-3034, 2018 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29923614
11.
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.
Breast Cancer Res Treat
; 169(3): 469-479, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29404806
12.
A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-ß.
Invest New Drugs
; 36(6): 1103-1109, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30311036
13.
Antibody-drug conjugates in triple negative breast cancer.
Future Oncol
; 14(25): 2651-2661, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-30175620
14.
Efficacy and safety of the trastuzumab biosimilar candidate CT-P6.
Future Oncol
; 14(19): 1909-1919, 2018 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-29482364
15.
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial.
Lancet Oncol
; 18(7): 917-928, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28592386
16.
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.
Breast Cancer Res
; 19(1): 89, 2017 Aug 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28764748
17.
Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma.
Br J Cancer
; 113(7): 1003-9, 2015 Sep 29.
Artigo
Inglês
| MEDLINE | ID: mdl-26393887
18.
CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells.
Breast Cancer Res Treat
; 151(3): 501-13, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25971596
19.
Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?
Curr Oncol Rep
; 17(10): 46, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26314739
20.
Genomic Signatures in Breast Cancer: Limitations of Available Predictive Data and the Importance of Prognosis.
Clin Adv Hematol Oncol
; 13(6 Suppl 6): 25-31, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26191943